Cargando…

Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease characterized by excessive lipid deposition. Lipid metabolism disturbances are possibly associated with hepatocyte inflammation development and oxidative balance impairment. The aim of our experiment was to examine the first moment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sztolsztener, Klaudia, Chabowski, Adrian, Harasim-Symbor, Ewa, Bielawiec, Patrycja, Konstantynowicz-Nowicka, Karolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464179/ https://www.ncbi.nlm.nih.gov/pubmed/32751983 http://dx.doi.org/10.3390/biom10081133

Ejemplares similares

Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2020)

Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2021)

Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity
por: Charytoniuk, Tomasz, et al.
Publicado: (2022)

Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD
por: Sztolsztener, Klaudia, et al.
Publicado: (2021)

Cannabidiol improves muscular lipid profile by affecting the expression of fatty acid transporters and inhibiting de novo lipogenesis
por: Bielawiec, Patrycja, et al.
Publicado: (2023)

High-Fat Feeding in Time-Dependent Manner Affects Metabolic Routes Leading to Nervonic Acid Synthesis in NAFLD
por: Konstantynowicz-Nowicka, Karolina, et al.
Publicado: (2019)

Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes
por: Harasim-Symbor, Ewa, et al.
Publicado: (2020)

The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes
por: Zywno, Hubert, et al.
Publicado: (2021)

Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
por: Bielawiec, Patrycja, et al.
Publicado: (2020)

Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats
por: Berk, Klaudia, et al.
Publicado: (2022)

How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
por: Bzdęga, Wiktor, et al.
Publicado: (2023)

Concentration-Dependent Attenuation of Pro-Fibrotic Responses after Cannabigerol Exposure in Primary Rat Hepatocytes Cultured in Palmitate and Fructose Media
por: Sztolsztener, Klaudia, et al.
Publicado: (2023)

Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway
por: Kołakowski, Adrian, et al.
Publicado: (2021)

Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
por: Berk, Klaudia, et al.
Publicado: (2021)

Asymptomatic Survivors of Childhood Acute Lymphoblastic Leukemia Demonstrate a Biological Profile of Inflamm-Aging Early in Life
por: Latoch, Eryk, et al.
Publicado: (2022)

New Evidence for the Role of Ceramide in the Development of Hepatic Insulin Resistance
por: Konstantynowicz-Nowicka, Karolina, et al.
Publicado: (2015)

Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis
por: Kozłowska, Dorota, et al.
Publicado: (2021)

Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?
por: Drygalski, Krzysztof, et al.
Publicado: (2017)

How Hypertension Affects Heart Metabolism
por: Polak-Iwaniuk, Agnieszka, et al.
Publicado: (2019)

Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
por: Wasilewska, Natalia, et al.
Publicado: (2018)

How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases
por: Dziemitko, Sylwia, et al.
Publicado: (2023)

Serum fatty acid profile in psoriasis and its comorbidity
por: Myśliwiec, Hanna, et al.
Publicado: (2017)

Lipid profile disturbances may predispose psoriatic patients to liver dysfunction
por: Kozłowska, Dorota, et al.
Publicado: (2021)

Abnormal serum fatty acid profile in psoriatic arthritis
por: Mysliwiec, Hanna, et al.
Publicado: (2019)

Lack of pronounced changes in the expression of fatty acid handling proteins in adipose tissue and plasma of morbidly obese humans
por: Grzegorczyk, Ewa Anna, et al.
Publicado: (2018)

N-Acetylcysteine Decreases Myocardial Content of Inflammatory Mediators Preventing the Development of Inflammation State and Oxidative Stress in Rats Subjected to a High-Fat Diet
por: Sztolsztener, Klaudia, et al.
Publicado: (2023)

Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
por: Charytoniuk, Tomasz, et al.
Publicado: (2020)

The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders
por: Charytoniuk, Tomasz, et al.
Publicado: (2022)

Antioxidants Supplementation Reduces Ceramide Synthesis Improving the Cardiac Insulin Transduction Pathway in a Rodent Model of Obesity
por: Hodun, Katarzyna, et al.
Publicado: (2021)

Serum sphingolipid level in psoriatic patients with obesity
por: Kozłowska, Dorota, et al.
Publicado: (2019)

Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients
por: Myśliwiec, Hanna, et al.
Publicado: (2016)

Delta-6 desaturase (Fads2) deficiency alters triacylglycerol/fatty acid cycling in murine white adipose tissue
por: Wang, Chenxuan, et al.
Publicado: (2023)

Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia
por: Konończuk, Katarzyna, et al.
Publicado: (2022)

Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis
por: Kołakowski, Adrian, et al.
Publicado: (2022)

Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease
por: Świderska, Magdalena, et al.
Publicado: (2017)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Arachidonic Acid Metabolism and Kidney Inflammation
por: Wang, Tianqi, et al.
Publicado: (2019)

Artemisia plants, arachidonic and other polyunsaturated fatty acids
por: Munyangi, Jérôme, et al.
Publicado: (2020)

Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation
por: Tan, Si-hua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pohkj0rcs108k9n0ecqj5vhsrh